Wery, C., Montero-Ruiz, L., Bonneil, E., Farran, M., Jehay, R., Garfia, Q. H., Fettweis, G., Blacher, S., Pottier, C., Cobraiville, G., Boumahd, Y., Peulen, O., Noël, A., Dequiedt, F., Fillet, M., & Sounni, N. E. (June 2026). Stearoyl‐CoA Desaturase‐1 Drives Tumor Growth by Interacting With Histone Deacetylase‐2 and Deacetylating Nucleophosmin‐1. MedComm, 7 (6). doi:10.1002/mco2.70809 |
Jehay, R. (03 July 2025). Radioresistance of colorectal cancer cells is driven by GPX4 and ferroptosis resistance [Poster presentation]. ISCAM 2025. |
Jehay, R. (17 June 2025). Radioresistance of colorectal cancer cells is driven by GPX4 and ferroptosis resistance [Poster presentation]. EACR2025, Lisbonne, Portugal. |
Jehay, R. (23 May 2025). Radioresistance of colorectal cancer cells is driven by GPX4 and ferroptosis resistance [Paper presentation]. EDT UMONS 2025. |
Pottier, C., Montero-Ruiz, L., Jehay, R., Wery, C., Baiwir, D., Mazzucchelli, G., Bekisz, S., Thissen, R., Josse, C., Rorive, A., Gofflot, S., Dahmani, A., Morisset, L., Collignon, J., Delvenne, P., Marangoni, E., Noël, A., Jerusalem, G., & Sounni, N. E. (2025). Targeting ferroptosis resistance resensitizes metastatic HR+HER2- breast cancer cells to palbociclib-hormone therapy. Cancer Communications. doi:10.1002/cac2.12646 |
Jehay, R. (2025). Targeting Ferroptosis Resistance to sensitize colorectal cancer cells to radiotherapy [Poster presentation]. TELEVIE SEMINAR 2025. |
Jehay, R. (03 July 2024). Targeting Ferroptosis Resistance To Sensitize Cancer Cells To Radiotherapy [Poster presentation]. ISCAM 2024. |